Currently out of the existing stock ratings of Catherine Ramsey Schulte, 82 are a BUY (85.42%), 14 are a HOLD (14.58%).

Catherine Ramsey Schulte

Work Performance Price Targets & Ratings Chart

Analyst Catherine Ramsey Schulte works at BAIRD with a stock forecast success ratio of 73.04% fulfilled within 118.2 days on average.

Catherine Ramsey Schulte’s has documented 200 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on MRVI, Maravai Lifesciences Holdings  at 09-May-2024.

Wall Street Analyst Catherine Ramsey Schulte

Analyst best performing recommendations are on EXAS (EXACT SCIENCES).
The best stock recommendation documented was for EXAS (EXACT SCIENCES) at 2/21/2019. The price target of $90 was fulfilled within 1 day with a profit of $6.72 (8.07%) receiving and performance score of 80.69.

Average potential price target upside

A Agilent Technologies CSTL Castle Biosciences ILMN Illumina NSTG NanoString Technologies NTRA Natera TWST Twist Bioscience Corp TMO Thermo Fisher Scientific WAT Waters EXAS EXACT Sciences MRVI Maravai Lifesciences Holdings 

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

163

$12.34 (8.19%)

135

1 months 21 days ago

7/9 (77.78%)

$21.66 (15.32%)

81

Hold

132

$-18.66 (-12.39%)

120

2 months 28 days ago

7/8 (87.5%)

$-5.01 (-3.66%)

151

Sell

125

$-25.66 (-17.03%)

120

2 months 28 days ago

10/12 (83.33%)

$-12.01 (-8.77%)

137

Sell

120

$-30.66 (-20.35%)

100

4 months 1 days ago

4/6 (66.67%)

$-9.88 (-7.61%)

109

Buy

165

$14.34 (9.52%)

150

5 months 6 days ago

7/9 (77.78%)

$27.05 (19.61%)

269

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Catherine Ramsey Schulte is most bullish on?

Potential upside of $-0.85 has been obtained for MRVI (MARAVAI LIFESCIENCES HOLDINGS )

What Year was the first public recommendation made by Catherine Ramsey Schulte?

On 2016

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?